BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3286112)

  • 21. The effects of cyclic adenosine monophosphate, forskolin, and theophylline on motility parameters in gossypol-treated human sperm.
    Cowart CL; London SN; Vernon MW; Pedigo NG
    Fertil Steril; 1994 May; 61(5):929-34. PubMed ID: 8174733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is high dosage testosterone an effective male contraceptive agent?
    Matsumoto AM
    Fertil Steril; 1988 Aug; 50(2):324-8. PubMed ID: 3396702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low dose gossypol for male contraception.
    Gu ZP; Mao BY; Wang YX; Zhang RA; Tan YZ; Chen ZX; Cao L; You GD; Segal SJ
    Asian J Androl; 2000 Dec; 2(4):283-7. PubMed ID: 11202417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaginal contraception with gossypol: a clinical study.
    Ratsula K; Haukkamaa M; Wichmann K; Luukkainen T
    Contraception; 1983 Jun; 27(6):571-6. PubMed ID: 6684533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive.
    Bremner WJ; Bagatell CJ; Steiner RA
    J Clin Endocrinol Metab; 1991 Sep; 73(3):465-9. PubMed ID: 1874925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A possible mechanism of gossypol-induced hypokalemia and its relation to gossypol dose].
    Wang YX; Chen ZX
    Shengzhi Yu Biyun; 1991 May; 11(2):34-8. PubMed ID: 12317367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I clinical trial of an injectable contraceptive for the male.
    Guha SK; Singh G; Anand S; Ansari S; Kumar S; Koul V
    Contraception; 1993 Oct; 48(4):367-75. PubMed ID: 8222664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
    Anderson RA; Wallace AM; Wu FC
    J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contraceptive efficacy of polyester-induced azoospermia in normal men.
    Shafik A
    Contraception; 1992 May; 45(5):439-51. PubMed ID: 1623716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
    Matsumoto AM
    J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gossypol-induced hypokalemia and role of exogenous potassium salt supplementation when used as an antispermatogenic agent in male langur monkey.
    Kumar M; Sharma S; Lohiya NK
    Contraception; 1997 Oct; 56(4):251-6. PubMed ID: 9408707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An analysis of the direct effects of gossypol on human spermatozoa.
    Aitken RJ; Liu J; Best FS; Richardson DW
    Int J Androl; 1983 Apr; 6(2):157-67. PubMed ID: 6862672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seminal cytology in the presence of varicocele.
    MacLeod J
    Fertil Steril; 1965; 16(6):735-57. PubMed ID: 5842235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
    Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
    Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitory effects of gossypol analogs on human sperm motility.
    Tanphaichitr N; Agulnick A; Hill JA
    Contraception; 1989 Jun; 39(6):687-97. PubMed ID: 2752755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of gossypol on human and monkey sperm motility in vitro.
    Chongthammakun S; Ekavipat C; Sanitwongse B; Pavasuthipaisit K
    Contraception; 1986 Sep; 34(3):323-31. PubMed ID: 3791997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancies associated with sperm concentrations below 10 million/ml in clinical studies of a potential male contraceptive method, monthly depot medroxyprogesterone acetate and testosterone esters.
    Barfield A; Melo J; Coutinho E; Alvarez-Sanchez F; Faundes A; Brache V; Leon P; Frick J; Bartsch G; Weiske WH; Brenner P; Mishell D; Bernstein G; Ortiz A
    Contraception; 1979 Aug; 20(2):121-7. PubMed ID: 487815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of gossypol acetic acid on the activity of LDH-C4 from human and rabbit spermatozoa.
    Eliasson R; Virji N
    Int J Androl; 1983 Feb; 6(1):109-12. PubMed ID: 6840877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between testosterone oenanthate-induced azoospermia and oligozoospermia in a male contraceptive study. IV. Suppression of endogenous testicular and adrenal androgens.
    Anderson RA; Wallace AM; Kicman AT; Wu FC
    Hum Reprod; 1997 Aug; 12(8):1657-62. PubMed ID: 9308789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.